What the Gut Can Teach Us About Migraine

Current Pain and Headache Reports

Volumn 19, Issue 7, 2015, Pages

  Hindiyeh, Nada ^a   Aurora, Sheena K ^a  

^a Stanford Medicine Children s Health   (United States)

Author keywords

Autonomic dysfunction; Gastric stasis; Gut microbiota; Migraine; Probiotics

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; FOOD ANTIGEN; IMMUNOGLOBULIN G ANTIBODY;

ANTIBODY TITER; BACTEROIDES THETAIOTAOMICRON; DIETARY INTAKE; DISEASE ASSOCIATION; EVOKED RESPONSE; GASTROINTESTINAL TRACT FUNCTION; GRAY MATTER; HIGH RISK POPULATION; HUMAN; HYPOTHALAMUS; INCIDENCE; INTESTINE FLORA; IRRITABLE COLON; LACTOBACILLUS PARACASEI; MIGRAINE; NAUSEA; NONHUMAN; PATHOPHYSIOLOGY; PREVALENCE; PROTEIN SECRETION; QUALITY OF LIFE; RESTING STATE NETWORK; REVIEW; STOMACH EMPTYING; STOMACH MOTILITY; STOMACH PARESIS; VOMITING; WHITE MATTER; CENTRAL NERVOUS SYSTEM; COMPLICATION; GASTROINTESTINAL DISEASES; GASTROPARESIS; INTESTINE INNERVATION; MIGRAINE DISORDERS; PHYSIOLOGY;

CENTRAL NERVOUS SYSTEM; ENTERIC NERVOUS SYSTEM; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MICROBIOME; GASTROPARESIS; HUMANS; MIGRAINE DISORDERS;

EID: 84930637494     PISSN: 15313433     EISSN: 15343081     Source Type: Journal    
DOI: 10.1007/s11916-015-0501-4     Document Type: Review

References (96)

1. Lipton RB, Stewart FW, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41:646–57.
2. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33:629–808.
3. Kurth T, Holtmann G, Neufang-Huber J, Gerken G, Diener HC. Prevalence of unexplained upper abdominal symptoms in patients with migraine. Cephalalgia. 2006;26:506–10.
4. Aurora SK, Papapetropoulos S, Kori SH, Kedar A, Abell TL. Gastric stasis in migraineurs: etiology, characteristics, and clinical and therapeutic implications. Cephalalgia. 2013;33:408–15.
5. Aamodt AH, Stovner LJ, Hagen K, Zwart J-A. Comorbidity of headache and gastrointestinal complaints. The head-HUNT study. Cephalalgia. 2008;28:144–51.
6. Cady RK, Farmer K, Dexter JK, Hall J. The bowel and migraine: update on celiac disease and irritable bowel syndrome. Curr Pain Headache Rep. 2012;16:278–86.
7. Selby G, Lance JW. Observations on 500 cases of migraine and allied vascular headache. J Neurol Neurosurg Psychiat. 1960;23:23.
8. Lipton RB, Buse DC, Saiers J, Fanning KM, Serrano D, Reed ML. Frequency and burden of headache-related nausea: results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache. 2013;53:93–103.
9. Bouras EP, Vazquez Roque MI, Aranda-Michel J. Gastroparesis: from concepts to management. Nutr Clin Pract. 2013;28:437–47.
10. Lee A. Gastroparesis: what is the current state-of-the-art for evaluation and medical management? What are the results? J Gastrointest Surg. 2013;17:1553–6.
11. Jung HK, Choung RS, Locke 3rd GR, Schleck CD, Zinsmeister AR, Szarka LA, et al. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology. 2009;136:1225–33.
12. Parkman HP, Hasler WL, Fisher RS. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology. 2004;127:1592–622.
13. Quigley EM. Changing face of irritable bowel syndrome. World J Gastroenterol. 2006;12:1–5.
14. Chang FY, Lu CL. Irritable bowel syndrome and migraine: bystanders or partners? J Neurogastroenterol Motil. 2013;19:301–11.
15. Hadjivassiliou M, Sanders DS, Grunewald RA, Woodroofe N, Boscolo S, Aeschlimann D. Gluten sensitivity: from gut to brain. Lancet Neurol. 2010;9:318–30.
16. Dimitrova AK, Ungaro RC, Lebwohl B, Lewis SK, Tennyson CA, Green MW, et al. Prevalence of migraine in patients with celiac disease and inflammatory bowel disease. Headache. 2013;53:344–55.
17. Furness JB. The enteric nervous system and neurogastroenterology. Nat Rev Gastroenterol Hepatol. 2012;9:286–94.
18. Benarroch EE. Enteric nervous system: functional organization and neurologic implications. Neurology. 2007;69:1953–7.
19. Gershon MD, Chalazonitis A, Rothman TP. From neural crest to bowel: development of the enteric nervous system. J Neurobiol. 1993;24:199–214.
20. Oh JH, Pasricha PJ. Recent advances in the pathophysiology and treatment of gastroparesis. J Neurogastroenterol Motil. 2013;19:18–24.
21. Browning KN, Travagli RA. Plasticity of vagal brainstem circuits in the control of gastric function. Neurogastroenterol Motil. 2010;22:1154–63.
22. Bailey TW, Hermes SM, Andresen MC, Aicher SA. Cranial visceral afferent pathways through the nucleus of the solitary tract to caudal ventrolateral medulla or paraventricular hypothalamus: target-specific synaptic reliability and convergence patterns. J Neurosci. 2006;26:11893–902.
23. Travagli RA, Hermann GE, Browning KN, Rogers RC. Brainstem circuits regulating gastric function. Annu Rev Physiol. 2006;68:279–305.
24. Ischiguchi T, Nakajima M, Sone H, Tada H, Kumagai AK, Takahashi T. Gastric distension-induced pyloric relaxation: central nervous system regulation and effects of acute hyperglycaemia in the rat. J Physiol. 2001;533:801–13.
25. Reddymasu SC, Bonino J, McCallum RW. Gastroparesis secondary to a demyelinating disease: a case series. BMC Gastroenterol. 2007;7:3.
26. Mayer EA. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci. 2013;12(8):453–66.
27. Holstege G, Bandler R, Saper CB. The emotional motor system. Prog Bran Res. 1996;107:3–6.
28. Mayer EA. The neurobiology of stress and gastrointestinal disease. Gut. 2000;47:861–9.
29. Olesen J, Burstein R, Ashina M, Tfelt-Hansen P. Origin of pain in migraine- evidence for peripheral sensitization. Lancet Neurol. 2009;8:679–90.
30. Waeber C, Moskowitz MA. Migraine as an inflammatory disorder. Neurology. 2005;64:9–15.
31. Moskowitz MA, Buzzi MG, Sakas DE, Linnik MD. Pain mechanisms underlying vascular headaches. Progress report 1989. Rev Neurol. 1989;145:181–93.
32. Cosentino G, Fierro B, Brighina F. From different neurophysiological methods to conflicting pathophysiological views in migraine: a critical review of literature. Clin Neurophysiol. 2014;125:1721–30.
33. Rossi R, Ambrosinin A, Buzzi MG. Prodromes and predictors of migraine attack. Funct Neurol. 2005;20:185–91.
34. Andreatta M, Puschmann AK, Sommer C, Weyers P, Pauli P, Muhlberger A. Altered processing of emotional stimuli in migraine: an event-related potential study. Cephalalgia. 2012;32:1101–8.
35. Bolay H. The first phase of a migraine attack resides in the cortex. J Neural Transm. 2012;119:569–74.
36. Alstadhaug KB. Migraine and the hypothalamus. Cephalalgia. 2009;29:809–17.
37. Noseda R, Burstein R. Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain. Pain. 2013;154:44–53. A good review on migraine pathophysiology reviewing recent data on the trigeminovascular pathway and its modulation by the brainstem and hypothalamus.
38. Denuelle M, Fabre N, Payoux P, Chollet F, Geraud G. Hypothalamic activation in spontaneous migraine attacks. Headache. 2007;47:1418–26.
39. Peroutka SJ. Migraine: a chronic sympathetic nervous system disorder. Headache. 2004;44:53–64.
40. Shechter A, Stewart WF, Silberstein SD, Lipton RB. Migraine and autonomic nervous system function: a population-based, case-control study. Neurology. 2002;58:422–7.
41. Gass JJ, Glaros AG. Autonomic dysregulation in headache patients. Appl Psychophysiol Biofeedback. 2013;38:257–63.
42. Takeshima T, Takao Y, Takahashi K. Pupillary sympathetic hypofunction and asymmetry in muscle contraction headache and migraine. Cephalalgia. 1987;7:257–62.
43. Takeshima T, Takao Y, Urakami K, Nishikawa S, Takahasi K. Muscle contraction headache and migraine. Cephalalgia. 1989;9:7–13.
44. Yerdelen D, Acil T, Goksel B, Karatas M. Autonomic function in tension-type headache. Acta Neurol Belg. 2007;107:108–11.
45. Raieli V, Giordano G, Spitaleri C, Consolo F, Buffa D, Santangelo G, et al. Migraine and cranial autonomic symptoms in children and adolescents: a clinical study. J Child Neurol. 2014; 1-5.
46. Aurora SK, Kori SH, Barrodale P, McDonald SA, Haseley D. Gastric stasis in migraine: more than just a paroxysmal abnormality during a migraine attack. Headache. 2006;46:57–63.
47. Yates BJ, Miller AD, Lucot JB. Physiological basis and pharmacology of motion sickness: an update. Brain Res Bull. 1998;47:395–406.
48. Hasler WL. Pathology of emesis: its autonomic basis. Handb Clin Neurol. 2013;117:337–52.
49. Kovacic K, Li BU. Childhood chronic nausea: is it just a queasy stomach? Curr Gastroenterol Rep. 2014;16:395.
50. Jericho H, Adams P, Zhang G, Rychlik K, Saps M. Nausea predicts delayed gastric emptying in children. J Pediatr. 2014;164:89–92.
51. Napadow V, Sheehan J, Kim J, LaCount L, Park K, Kaptchuk TJ, et al. The brain circuitry underlying the temporal evolution of nausea in humans. Cereb Cortex. 2013;23:806–13.
52. Chai NC, Shapiro RE, Rapoport AM. Why does vomiting stop a migraine attack? Curr Pain Headache Rep. 2013;17:362–7.
53. Volans GN. The effect of metoclopramide on the absorption of effervescent aspirin in migraine. Br J clin Pharmac. 1975;2:57–63.
54. Volans GN. Migraine and drug absorption. Clin Pharmacokinet. 1978;3:313–8.
55. Aurora SK, Kori S, Barrodale P, Nelsen A, McDonald S. Gastric stasis occurs in spontaneous, visually induced, and interictal migraine. Headache. 2007;47:1443–6.
56. Yu YH, Jo Y, Junn JY, Kim BK, Seok JW. Gastric emptying in migraine: a comparison with functional dyspepsia. J Neurogastroenterol Motil. 2012;18:412–8.
57. Yalcin H, Okuyucu EE, Ucar E, Duman T, Yilmazer S. Changes in liquid emptying in migraine patients: diagnosed with liquid phase gastric emptying scintigraphy. Intern Med J. 2012;42:455–9.
58. Abell TL, Adams KA, Boles RG, Bousvaros A, Chong SK, Fleisher DR, et al. Cyclic vomiting syndrome in adults. Neurogastroenterol Motil. 2008;20:269–84.
59. Li BUK, Murray RD, Heitlinger LA, Robbins JL, Hayes JR. Is cyclic vomiting syndrome related to migraine? J Pediatr. 1999;134:567–72.
60. Prakash C, Staiano A, Rothbaum RJ, Clouse RE. Similarities in cyclic vomiting syndrome across age groups. Am J Gastroenterol. 2001;96:684–8.
61. Rashed H, Abell TL, Familoni BO, Cardoso S. Autonomic function in cyclic vomiting syndrome and classic migraine. Dig Dis Sci. 1999;44:74–8.
62. Chelimsky TC, Chelimsky GG. Autonomic abnormalities in cyclic vomiting syndrome. J Pediatr Gastroenterol Nutr. 2007;44:326–30.
63. Christensen CJ, Johnson WD, Abell TL. Patients with cyclic vomiting pattern and diabetic gastropathy have more migraines, abnormal electrogastrograms, and gastric emptying. Scand J Gastroenterol. 2008;43:1076–81.
64. Hejazi RA, Lavenbarg TH, Pasnoor M, Dimachkie M, Foran P, Jerbelin L, et al. Autonomic nerve function in adult patients with cyclic vomiting syndrome. Neurogastroenterol Motil. 2011;23:439–43.
65. Evans RW, Whyte C. Cyclic vomiting syndrome and abdominal migraine in adults and children. Headache. 2013;53:984–93.
66. Myers B, Greenwood-Van Meerveld B. Role of anxiety in the pathophysiology of irritable bowel syndrome: importance of the amygdala. Auton Neurosci. 2009;3:47.
67. Seminowicz DA, Labus JS, Bueller JA, Tillsch K, Naliboff BD, Bushnell MC, et al. Regional gray matter density changes in brains of patients with irritable bowel syndrome. Gastroenterology. 2010;139:48–57.
68. Piche M, Chen JI, Roy M, Poitras P, Bouin M, Rainville P. Thicker posterior insula is associated with disease duration in women with irritable bowel syndrome (IBS) whereas thicker orbitofrontal cortex predicts reduced pain inhibition in both IBS patients and controls. J Pain. 2013;14:1217–26.
69. Lau CI, Lin CC, Chen WH, Wang HC, Kao CH. Association between migraine and irritable bowel syndrome: a population-based retrospective cohort study. Eur J Neurol. 2014;21:1198–204.
70. Robbins MS. Cluster belly: a variant of irritable bowel syndrome. Headache. 2014;54:1644–6.
71. Van der WD, Sturm CA. Antibiotic decontamination of the digestive tract of mice. Technical procedures. Lab Anim Care. 1968;18:1–10.
72. Verdu EF, Bercik P, Verma-Gandhu M, et al. Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut. 2006;55:182–90.
73. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science. 2001;291:881–4.
74. Skehel PA, Armitage BA, Bartsch D, et al. Proteins functioning in synaptic transmission at the sensory to motor synapse of Aplysia. Neuropharmacology. 1995;34:1379–85.
75. Bailey MT, Coe CL. Maternal separation disrupts the integrity of the intestinal microflora in infant rhesus monkeys. Dev Psychobiol. 1999;35:146–55.
76. Collins SM, Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology. 2009;136:2003–14.
77. Desbonnet L, Garrett L, Clarke G, Bienenstock J, Dinan TG. The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J Psychiatr Res. 2008;43:164–74.
78. Saulneir DM, Ringel Y, Heyman MB, Foster JA, Bercik P, Shulman RJ, et al. The intestinal microbiome, probiotics and prebiotics in neurogastroenterology. Gut Microbes. 2013;4:17–27. Good review of the “brain-gut axis”and discussion of the use of prebiotics and probiotics in neurogastroenterology. Both animal and human studies are highlighted as well as the neuroimmune system on the composition of the microbiota.
79. Diaz Heijtz R, Wang S, Anuar F, Qian Y, Björkholm B, Samuelsson A, et al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A. 2011;108:3047–52.
80. Neufeld KM, Kang N, Bienenstock J, Foster JA. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil. 2011;23:255–64.
81. Bercik P, Verdu EF, Foster JA, Macri J, Potter M, Huang X, et al. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology. 2010;139:2102–12.
82. Messaoudi M, Lalonde R, Violle N, Javelot H, Desor D, Nejdi A, et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr. 2011;105:755–64.
83. Lyte M, Li W, Opitz N, Gaykema RP, Goehler LE. Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium. Physiol Behav. 2006;89:350–7.
84. Adams JB, Johansen LJ, Powell LD, Quig D, Rubin RA. Gastrointestinal flora and gastrointestinal status in children with autism—comparisons to typical children and correlation with autism severity. BMC Gastroenterol. 2011;11:22.
85. Wang L, Christophersen CT, Sorich MJ, Gerber JP, Angley MT, Conlon MA. Low relative abundances of the mucolytic bacterium Akkermansia muciniphila and Bifidobacterium spp. in feces of children with autism. Appl Environ Microbiol. 2011;77:6718–21.
86. Finegold SM, Dowd SE, Gontcharova V, Liu C, Henley KE, Wolcott RD, et al. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe. 2010;16:444–53.
87. Sandler RH, Finegold SM, Bolte ER, Buchanan CP, Maxwell AP, Väisänen ML, et al. Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol. 2000;15:429–35.
88. Collins SM, Surette M, Bercik P. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol. 2012;10:735–42.
89. Tillisch K, Labus J, Kilpatrick L, Jiang Z, Stains J, Ebrat B, et al. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology. 2013;144:1394–401.
90. Finkel AG, Yerry JA, Mann JD. Dietary considerations in migraine management: does a consistent diet improve migraine? Curr Pain Headache Rep. 2013;17:373.
91. Akerman S, Holland PR, Goadsby PJ. Diencephalic and brainstem mechanisms in migraine. Nat Rev Neurosci. 2011;12:570–84.
92. Grazzi L, Corsini E, Ciusani E, Usai S, Vasco C, Bussone G. Evaluation of immune parameters in chronic migraine with medication overuse. Neurol Sci. 2014;35:171–3.
93. Aydinlar EI, Dikne PY, Tiftikci A, Saruc M, Aksu M, Gunsoy HG, et al. IgG-based elimination diet in migraine plus irritable bowel syndrome. Headache. 2013;53:514–25. A double-blind, randomized, controlled cross-over clinical trial evaluating the therapeutic potential of IgG based elimination diet in patients with migraine and IBS. Results suggest symptom decrease and improved quality of life with these changes.
94. Sensenig J, Marrongelle J, Johnson M, Staverosky T. Treatment of migraine with targeted nutrition focused on improved assimilation and elimination. Altern Med Rev. 2001;6:488–94.
95. Ramsden CE, Faurot KR, Zamora D, Suchimdran CM, Macintosh BA, Gaylord S, et al. Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: a randomized trial. Pain. 2013;154:2441–51.
96. Bunner AE, Agarwal U, Gonzales JF, Valente F, Barnard ND. Nutrition intervention for migraine: a randomized crossover trial. J Headache Pain. 2014;15:69.